Protagenic Therapeutics, Inc. held its 2024 Annual Meeting on February 21, 2025, where stockholders elected directors, approved stock option repricing, ratified an accounting firm, and amended the equity incentive plan.
AI Assistant
PROTAGENIC THERAPEUTICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.